Angiographic no-reflow and six-month mortality in elderly (>/= 75 years old) Asian patients undergoing primary percutaneous coronary intervention: A single center experience from 1998 to 2007.
BACKGROUND
We sought to report the incidence of angiographic no-reflow and clinical outcomes of elderly patients who have undergone primary percutaneous coronary intervention at a tertiary institution in Singapore over a period of 10 years.


METHODS
A total of 141 patients (60% male) aged 75 or above underwent primary PCI between 1998 and 2007. Their average age was 80+/-5 years. Cardiogenic shock complicating STEMI on presentation accounted for 15% of the patients.


RESULTS
At baseline, 103 (73%) patients have impaired TIMI flow grade (TIMI 0-2), and 38 (27%) have normal flow (TIMI 3). At the end of the procedure, 44 (31.2%) patients had no-reflow phenomenon (TIMI 0-2), whereas 97 (68.8%) achieved normal antegrade flow. Post-procedure corrected TIMI frame count was analyzable in 66% (n=93) of the patients. Post-procedure corrected TIMI frame count was>28 in 37.6% (n=35) of patients. In-hospital, 30-day and six-month mortalities were 20.6, 25.5% and 27.7%, respectively. Multivariable analysis showed that age 80 or above, low systolic blood pressure and final TIMI 0-2 flow independently predicted six-month mortality.


CONCLUSIONS
We found that one-third of the treated patients developed no-reflow phenomenon. Six-month mortality was 27.7%, most were cardiac deaths that occurred during index hospitalization.
Lee
Chi-Hang
CH
Department of Medicine, National University of Singapore, Singapore. mdclchr@nus.edu.sg
Tai
Bee-Choo
BC
Low
Adrian F
AF
Teo
Swee-Guan
SG
Lim
Yean-Teng
YT
Tan
Huay-Cheem
HC
D000367:Age Factors; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D044466:Asian People; D015331:Cohort Studies; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D054318:No-Reflow Phenomenon / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000628:therapy*; D012189:Retrospective Studies; D012846:Singapore; D015996:Survival Rate; D016896:Treatment Outcome